A citation-based method for searching scientific literature

Katherine E Kunigelis, Michael A Vogelbaum. Neurosurg Clin N Am 2021
Times Cited: 3







List of co-cited articles
10 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Convection-enhanced drug delivery for glioblastoma: a review.
Randy S D'Amico, Manish K Aghi, Michael A Vogelbaum, Jeffrey N Bruce. J Neurooncol 2021
9
66

Evaluating infusate parameters for direct drug delivery to the brainstem: a comparative study of convection-enhanced delivery versus osmotic pump delivery.
Julian S Rechberger, Erica A Power, Victor M Lu, Liang Zhang, Jann N Sarkaria, David J Daniels. Neurosurg Focus 2020
7
66

Nanotechnology Applications for Diffuse Intrinsic Pontine Glioma.
Amy Lee Bredlau, Suraj Dixit, Chao Chen, Ann-Marie Broome. Curr Neuropharmacol 2017
13
66

The distribution, clearance, and brainstem toxicity of panobinostat administered by convection-enhanced delivery.
William G B Singleton, Alison S Bienemann, Max Woolley, David Johnson, Owen Lewis, Marcella J Wyatt, Stephen J P Damment, Lisa J Boulter, Clare L Killick-Cole, Daniel J Asby,[...]. J Neurosurg Pediatr 2018
35
66

Convection-enhanced delivery of macromolecules in the brain.
R H Bobo, D W Laske, A Akbasak, P F Morrison, R L Dedrick, E H Oldfield. Proc Natl Acad Sci U S A 1994
962
66

Effective Drug Delivery in Diffuse Intrinsic Pontine Glioma: A Theoretical Model to Identify Potential Candidates.
Fatma E El-Khouly, Dannis G van Vuurden, Thom Stroink, Esther Hulleman, Gertjan J L Kaspers, N Harry Hendrikse, Sophie E M Veldhuijzen van Zanten. Front Oncol 2017
13
66

Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors.
Jessica I Griffith, Sneha Rathi, Wenqiu Zhang, Wenjuan Zhang, Lester R Drewes, Jann N Sarkaria, William F Elmquist. Pharmaceutics 2020
8
66

Convection-enhanced delivery to the central nervous system.
Russell R Lonser, Malisa Sarntinoranont, Paul F Morrison, Edward H Oldfield. J Neurosurg 2015
91
66

Focused ultrasound mediated blood-brain barrier opening is safe and feasible in a murine pontine glioma model.
Zachary K Englander, Hong-Jian Wei, Antonios N Pouliopoulos, Ethan Bendau, Pavan Upadhyayula, Chia-Ing Jan, Eleanora F Spinazzi, Nina Yoh, Masih Tazhibi, Nicholas M McQuillan,[...]. Sci Rep 2021
6
66

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy.
Christine E Brown, Darya Alizadeh, Renate Starr, Lihong Weng, Jamie R Wagner, Araceli Naranjo, Julie R Ostberg, M Suzette Blanchard, Julie Kilpatrick, Jennifer Simpson,[...]. N Engl J Med 2016
710
66

Phase I trial of convection-enhanced delivery of IL13-Pseudomonas toxin in children with diffuse intrinsic pontine glioma.
John D Heiss, Aria Jamshidi, Smit Shah, Staci Martin, Pamela L Wolters, Davis P Argersinger, Katherine E Warren, Russell R Lonser. J Neurosurg Pediatr 2018
22
33

Activation of latent human immunodeficiency virus by the histone deacetylase inhibitor panobinostat: a pilot study to assess effects on the central nervous system.
Thomas A Rasmussen, Martin Tolstrup, Holger Jon Møller, Christel R Brinkmann, Rikke Olesen, Christian Erikstrup, Alex L Laursen, Lars Østergaard, Ole S Søgaard. Open Forum Infect Dis 2015
34
33




Primary Neoplasms of the Pediatric Brain.
Camilo Jaimes, Tina Young Poussaint. Radiol Clin North Am 2019
5
33

In vitro drug response and efflux transporters associated with drug resistance in pediatric high grade glioma and diffuse intrinsic pontine glioma.
Susanna J E Veringa, Dennis Biesmans, Dannis G van Vuurden, Marc H A Jansen, Laurine E Wedekind, Ilona Horsman, Pieter Wesseling, William Peter Vandertop, David P Noske, GertJan J L Kaspers,[...]. PLoS One 2013
73
33

The 100 Most-Cited Articles About Convection-Enhanced Delivery to the Brain: A Bibliometric Analysis.
Victor M Lu, Julian S Rechberger, Benjamin T Himes, David J Daniels. World Neurosurg 2019
4
33

Clinical efficacy of anakinra to mitigate CAR T-cell therapy-associated toxicity in large B-cell lymphoma.
Paolo Strati, Sairah Ahmed, Partow Kebriaei, Loretta J Nastoupil, Catherine M Claussen, Grace Watson, Sandra B Horowitz, Anne Rain T Brown, Bryan Do, Maria A Rodriguez,[...]. Blood Adv 2020
39
33

Targeting Macrophages in Cancer: From Bench to Bedside.
Ashleigh R Poh, Matthias Ernst. Front Oncol 2018
211
33

Patient-Reported Neuropsychiatric Outcomes of Long-Term Survivors after Chimeric Antigen Receptor T Cell Therapy.
Julia Ruark, Erin Mullane, Nancy Cleary, Ana Cordeiro, Evandro D Bezerra, Vicky Wu, Jenna Voutsinas, Bronwen E Shaw, Kathryn E Flynn, Stephanie J Lee,[...]. Biol Blood Marrow Transplant 2020
30
33

Plasma Exchange Can Be an Alternative Therapeutic Modality for Severe Cytokine Release Syndrome after Chimeric Antigen Receptor-T Cell Infusion: A Case Report.
Xia Xiao, Xiaoyuan He, Qing Li, Huan Zhang, Juanxia Meng, Yanyu Jiang, Qi Deng, Mingfeng Zhao. Clin Cancer Res 2019
22
33

Point mutation in CD19 facilitates immune escape of B cell lymphoma from CAR-T cell therapy.
Zhen Zhang, Xinfeng Chen, Yonggui Tian, Feng Li, Xuan Zhao, Jinyan Liu, Chang Yao, Yi Zhang. J Immunother Cancer 2020
10
33

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.
Shannon L Maude, Theodore W Laetsch, Jochen Buechner, Susana Rives, Michael Boyer, Henrique Bittencourt, Peter Bader, Michael R Verneris, Heather E Stefanski, Gary D Myers,[...]. N Engl J Med 2018
33

Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia.
C Imai, K Mihara, M Andreansky, I C Nicholson, C-H Pui, T L Geiger, D Campana. Leukemia 2004
462
33

Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia.
Bianca D Santomasso, Jae H Park, Darin Salloum, Isabelle Riviere, Jessica Flynn, Elena Mead, Elizabeth Halton, Xiuyan Wang, Brigitte Senechal, Terence Purdon,[...]. Cancer Discov 2018
301
33

CAR T cells and checkpoint inhibition for the treatment of glioblastoma.
Steven H Shen, Karolina Woroniecka, Andrew B Barbour, Peter E Fecci, Luis Sanchez-Perez, John H Sampson. Expert Opin Biol Ther 2020
13
33

Pre-clinical assessment of chimeric antigen receptor t cell therapy targeting CD19+ B cell malignancy.
Sheng-I Hu, Ming-Chin Ko, Yi-Han Dai, Hsin-An Lin, Lih-Chyang Chen, Kuo-Yang Huang, Te-Ling Pang, Cheng-Yi Kuo, Hsin-Chung Lin. Ann Transl Med 2020
2
50

ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.
Daniel W Lee, Bianca D Santomasso, Frederick L Locke, Armin Ghobadi, Cameron J Turtle, Jennifer N Brudno, Marcela V Maus, Jae H Park, Elena Mead, Steven Pavletic,[...]. Biol Blood Marrow Transplant 2019
668
33

Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors.
Vincent Yi Sheng Oei, Marta Siernicka, Agnieszka Graczyk-Jarzynka, Hanna Julie Hoel, Weiwen Yang, Daniel Palacios, Hilde Almåsbak, Malgorzata Bajor, Dennis Clement, Ludwig Brandt,[...]. Cancer Immunol Res 2018
37
33

Pharmacologic management of cognitive impairment induced by cancer therapy.
Philipp Karschnia, Michael W Parsons, Jorg Dietrich. Lancet Oncol 2019
31
33

EGFRvIII mCAR-modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss.
John H Sampson, Bryan D Choi, Luis Sanchez-Perez, Carter M Suryadevara, David J Snyder, Catherine T Flores, Robert J Schmittling, Smita K Nair, Elizabeth A Reap, Pamela K Norberg,[...]. Clin Cancer Res 2014
177
33


Primary dural lymphomas: Clinical presentation, management, and outcome.
Philipp Karschnia, Tracy T Batchelor, Justin T Jordan, Brian Shaw, Sebastian F Winter, Frank J Barbiero, Leon D Kaulen, Niklas Thon, Joerg-Christian Tonn, Anita J Huttner,[...]. Cancer 2020
6
33

Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma.
Tarec Christoffer El-Galaly, Chan Yoon Cheah, Mette Dahl Bendtsen, Grzegorz S Nowakowski, Roopesh Kansara, Kerry J Savage, Joseph M Connors, Laurie H Sehn, Neta Goldschmidt, Adir Shaulov,[...]. Eur J Cancer 2018
33
33

DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality.
Kitsada Wudhikarn, Martina Pennisi, Marta Garcia-Recio, Jessica R Flynn, Aishat Afuye, Mari Lynne Silverberg, Molly A Maloy, Sean M Devlin, Connie Lee Batlevi, Gunjan L Shah,[...]. Blood Adv 2020
18
33

Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas.
D Yan, J Kowal, L Akkari, A J Schuhmacher, J T Huse, B L West, J A Joyce. Oncogene 2017
95
33

Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas.
Katrin Aslan, Verena Turco, Jens Blobner, Jana K Sonner, Anna Rita Liuzzi, Nicolás Gonzalo Núñez, Donatella De Feo, Philipp Kickingereder, Manuel Fischer, Ed Green,[...]. Nat Commun 2020
49
33

Direct convective delivery of adeno-associated virus gene therapy for treatment of neurological disorders.
Russell R Lonser, Asad S Akhter, Mirosław Zabek, J Bradley Elder, Krystof S Bankiewicz. J Neurosurg 2020
4
33

CAR T-Cell Therapy Is Effective but Not Long-Lasting in B-Cell Lymphoma of the Brain.
Tongjuan Li, Lei Zhao, Yuanyuan Zhang, Yi Xiao, Di Wang, Liang Huang, Liya Ma, Liting Chen, Songya Liu, Xiaolu Long,[...]. Front Oncol 2020
5
33

In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy.
Lukas Marcelis, Asier Antoranz, Anne-Marie Delsupehe, Pauline Biesemans, Julio Finalet Ferreiro, Koen Debackere, Peter Vandenberghe, Gregor Verhoef, Olivier Gheysens, Giorgio Cattoretti,[...]. Cancer Immunol Immunother 2020
10
33

Next-generation cell therapies: the emerging role of CAR-NK cells.
Rafet Basar, May Daher, Katayoun Rezvani. Blood Adv 2020
29
33

PD-1 blockade modulates chimeric antigen receptor (CAR)-modified T cells: refueling the CAR.
Elise A Chong, J Joseph Melenhorst, Simon F Lacey, David E Ambrose, Vanessa Gonzalez, Bruce L Levine, Carl H June, Stephen J Schuster. Blood 2017
261
33

CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients.
Barbara Savoldo, Carlos Almeida Ramos, Enli Liu, Martha P Mims, Michael J Keating, George Carrum, Rammurti T Kamble, Catherine M Bollard, Adrian P Gee, Zhuyong Mei,[...]. J Clin Invest 2011
668
33


Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta /CD28 receptor.
John Maher, Renier J Brentjens, Gertrude Gunset, Isabelle Rivière, Michel Sadelain. Nat Biotechnol 2002
586
33

Autoimmune disease-related primary CNS lymphoma: systematic review and meta-analysis.
Leon D Kaulen, Philipp Karschnia, Jorg Dietrich, Joachim M Baehring. J Neurooncol 2020
2
50

Long-term in vivo microscopy of CAR T cell dynamics during eradication of CNS lymphoma in mice.
Matthias Mulazzani, Simon P Fräßle, Iven von Mücke-Heim, Sigrid Langer, Xiaolan Zhou, Hellen Ishikawa-Ankerhold, Justin Leube, Wenlong Zhang, Sarah Dötsch, Mortimer Svec,[...]. Proc Natl Acad Sci U S A 2019
28
33

KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma.
Michael Wang, Javier Munoz, Andre Goy, Frederick L Locke, Caron A Jacobson, Brian T Hill, John M Timmerman, Houston Holmes, Samantha Jaglowski, Ian W Flinn,[...]. N Engl J Med 2020
305
33

How I treat primary CNS lymphoma.
Andrés J M Ferreri. Blood 2011
109
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.